home.aspx
 
EVENTS

BIOFIT 2019
BIOFIT 2019
December 10-11, 2019
With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming fro...

SiriusDecisions 2019 Technology Exchange
SIRIUSDECISIONS 2019 TECHNOLOGY EXCHANGE
December 09-11, 2019
The drive for growth never ceases for b-to-b organizations, and more than ever technology is at the centre of enabling that progress. Gone are the days however when a disparate, disconnected set of platforms strewn across sales, marketing an product can serve the organization effectively. An aligned...

Bionical

Everyone at Bionical shares an energy and passion to deliver services that ultimately lead to better lives for patients. We deliver better access to medicines, improve patient adherence/persistence with prescribed treatments and provide healthcare professionals with unique tools to enhance patient communication. Our expertise in behavioral science gives our clients insight into designing services optimally for real world challenges.

RELATED NEWS


MEMBERS of a pharmaceutical company based in Chippenham pedalled away for a good cause over the weekend as they cycled a gruelling 250 miles from Paris to Chippenham in just three days....

READ MORE

The US Food and Drug Administration (FDA) has granted accelerated approval to AstraZeneca’s Imfinzi (durvalumab) to treat patients with locally advanced or metastatic urothelial carcinoma (mUC)....

READ MORE

Doctors and aid organisations have called upon the Competition Commission of India and the price regulator to step in to ward off the monopoly over a new HIV drug, dolutegravir, which received the approval of the Indian drug controller last month....

READ MORE

Hemogenyx Pharmaceuticals plc ("Hemogenyx" or the "Company")(HEMO.L), the biopharmaceutical group developing new therapies and treatments designed to transform bone marrow transplantation for the treatment of blood diseases, announces its Final Results for the year ended 31 December 2018. It was an important year for Hemogenyx both scientifically and commercially as we progressed and diversified our product pipeline and commenced collaborations with several key pharmaceutical...

READ MORE

In response to a petition from Koios Pharmaceuticals LLC, the United States Patent and Trademark Office (“PTO”) has instituted inter partes review of the sole Orange-Book listed patent protecting Rasuvo®—a high-cost rheumatoid arthritis treatment—from generic competition. The PTO will now review the validity of all twenty-two claims of U.S. Patent 8,664,231, and on multiple grounds. In reaching its decision, the PTO noted that it was “persuaded that there is a reasonable likelihood that Petition...

READ MORE

Shares of Teva Pharmaceutical Industries (NYSE:TEVA), a developer of brand-name drugs and the largest manufacturer of generic drugs in the world, continued its fairly steady....

READ MORE

EVENTS

SiriusDecisions 2019 Technology Exchange
SIRIUSDECISIONS 2019 TECHNOLOGY EXCHANGE
December 09-11, 2019
The drive for growth never ceases for b-to-b organizations, and more than ever technology is at the centre of enabling that progress. Gone are the days however when a disparate, disconnected set of platforms strewn across sales, marketing an product can serve the organization effectively. An aligned...

BIOFIT 2019
BIOFIT 2019
December 10-11, 2019
With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming fro...